SCHEMBL9197151

SCHEMBL9197151

CCOC(=O)C(C)OC(=O)Oc1ccc(OC(=O)OC(C)C(=O)OCC)nc1

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TSHR P16473 1/20 0.40
ACACB O00763 12/20 0.40
ACACA Q13085 5/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.36
ALDH1A1 P00352 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MAPT P10636 1/20 0.36
CCNC P24863 1/20 0.36
CDK8 P49336 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9199674 0.86 ACACB (0.39) L3MBTL1ACACBACACAKMT2AMEN1
SCHEMBL9199601 0.86 ACACB (0.39) L3MBTL1ACACBACACAALDH1A1MAPT
SCHEMBL19664385 0.84 KMT2A (0.43) L3MBTL1ACACBACACAKMT2AMEN1
SCHEMBL9196824 0.80 L3MBTL1 (0.38) LMNAL3MBTL1TSHRACACBKMT2A
SCHEMBL12150066 0.78 CCNC (0.53) LMNAKMT2AMEN1ALDH1A1MAPT
SCHEMBL11277376 0.77 MAPT (0.53) LMNAL3MBTL1ACACBKMT2AMEN1
SCHEMBL14342283 0.77 L3MBTL1 (0.50) LMNAL3MBTL1TSHRKMT2AMEN1
SCHEMBL8096967 0.76 ACACB (0.42) LMNAACACBACACAKMT2AMEN1
SCHEMBL9199754 0.75 ACACB (0.40) LMNAL3MBTL1TSHRACACBACACA
SCHEMBL5132689 0.74 MAPT (0.48) LMNAL3MBTL1TSHRACACBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0278452-B1 2,4- and 2,5-Pyridine-dicarboxylic-acid derivatives, process for their preparation, their use and medicines based on these compounds HOECHST AG (DE) 1995-05-24 EP disclosed
EP-0278452-A2 2,4- and 2,5-Pyridine-dicarboxylic-acid derivatives, process for their preparation, their use and medicines based on these compounds HOECHST AKTIENGESELLSCHAFT (DE) 1988-08-17 EP disclosed